Haemophilia trials in Serbia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Where

  Belgrade, Niš

  Age

  1 year to 74 years

  People

  245 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05145127 · EU 2022-500470-33-00
• Phase 4Taking people
  Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

  Where

  Belgrade

  Age

  12 years and over

  People

  28 worldwide

  Run by

  Octapharma

  See details and how to joinNCT05935358
• Phase 4Taking people
  Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

  Where

  Belgrade

  Age

  12 years and over

  People

  28 worldwide

  Run by

  Octapharma

  See details and how to joinNCT05936580